{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:51:30Z","timestamp":1774281090553,"version":"3.50.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,8,2]],"date-time":"2015-08-02T00:00:00Z","timestamp":1438473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12308-015-0256-1","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T02:38:24Z","timestamp":1438396704000},"page":"143-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Myeloproliferative neoplasms in children"],"prefix":"10.1007","volume":"8","author":[{"given":"Inga","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,2]]},"reference":[{"key":"256_CR1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.5858\/2006-130-1133-CIM","volume":"130","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Chang CC (2006) Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis. Arch Pathol Lab Med 130:1133\u20131143. doi: 10.1043\/1543-2165(2006)130[1133:CIM]2.0.CO;2","journal-title":"Arch Pathol Lab Med"},{"key":"256_CR2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/08880018.2012.727064","volume":"29","author":"A Akyay","year":"2012","unstructured":"Akyay A, Solmaz OA (2012) Myelofibrosis associated with vitamin D deficiency rickets in an older aged child. Pediatr Hematol Oncol 29:691\u2013693. doi: 10.3109\/08880018.2012.727064","journal-title":"Pediatr Hematol Oncol"},{"key":"256_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1365-2141.2000.01977.x","volume":"109","author":"RA Altura","year":"2000","unstructured":"Altura RA, Head DR, Wang WC (2000) Long-term survival of infants with idiopathic myelofibrosis. Br J Haematol 109:459\u2013462","journal-title":"Br J Haematol"},{"key":"256_CR4","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/pbc.25211","volume":"61","author":"W An","year":"2014","unstructured":"An W, Wan Y, Guo Y, Chen X, Ren Y, Zhang J, Chang L, Wei W, Zhang P, Zhu X (2014) CALR mutation screening in pediatric primary myelofibrosis. Pediatr Blood Cancer 61:2256\u20132262. doi: 10.1002\/pbc.25211","journal-title":"Pediatr Blood Cancer"},{"key":"256_CR5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1600-0609.2002.01610.x","volume":"68","author":"B Andreasson","year":"2002","unstructured":"Andreasson B, Swolin B, Kutti J (2002) Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia. Eur J Haematol 68:189\u2013193","journal-title":"Eur J Haematol"},{"key":"256_CR6","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.1999.17.9.2954","volume":"17","author":"G Barosi","year":"1999","unstructured":"Barosi G (1999) Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 17:2954\u20132970","journal-title":"J Clin Oncol"},{"key":"256_CR7","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood.V98.12.3249","volume":"98","author":"G Barosi","year":"2001","unstructured":"Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, Marchetti M, Frassoni F (2001) Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 98:3249\u20133255","journal-title":"Blood"},{"key":"256_CR8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1586\/14737140.2.3.330","volume":"2","author":"NI Berlin","year":"2002","unstructured":"Berlin NI (2002) Polycythemia vera: diagnosis and treatment 2002. Expert Rev Anticancer Ther 2:330\u2013336. doi: 10.1586\/14737140.2.3.330","journal-title":"Expert Rev Anticancer Ther"},{"key":"256_CR9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1542\/peds.55.6.861","volume":"55","author":"LA Boxer","year":"1975","unstructured":"Boxer LA, Camitta BM, Berenberg W, Fanning JP (1975) Myelofibrosis-myeloid metaplasia in childhood. Pediatrics 55:861\u2013865","journal-title":"Pediatrics"},{"key":"256_CR10","first-page":"209","volume":"2","author":"JY Cahn","year":"1987","unstructured":"Cahn JY, Plouvier E, Flesch M, Carbillet JP, Herve P (1987) T cell-depleted allogeneic bone marrow transplantation in a case of childhood idiopathic myelofibrosis. Bone Marrow Transplant 2:209\u2013211","journal-title":"Bone Marrow Transplant"},{"key":"256_CR11","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/leu.2009.141","volume":"23","author":"N Carbuccia","year":"2009","unstructured":"Carbuccia N, Murati A, Trouplin V, Brecqueville M, Adelaide J, Rey J, Vainchenker W, Bernard OA, Chaffanet M, Vey N et al (2009) Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia 23:2183\u20132186. doi: 10.1038\/leu.2009.141","journal-title":"Leukemia"},{"key":"256_CR12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00277-004-0985-1","volume":"84","author":"H Cario","year":"2005","unstructured":"Cario H (2005) Childhood polycythemias\/erythrocytoses: classification, diagnosis, clinical presentation, and treatment. Ann Hematol 84:137\u2013145. doi: 10.1007\/s00277-004-0985-1","journal-title":"Ann Hematol"},{"key":"256_CR13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2008.07220.x","volume":"142","author":"H Cario","year":"2008","unstructured":"Cario H, Schwarz K, Herter JM, Komrska V, McMullin MF, Minkov M, Niemeyer C, Pospisilova D, Reinhard H, Debatin KM et al (2008) Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera. Br J Haematol 142:622\u2013626. doi: 10.1111\/j.1365-2141.2008.07220.x","journal-title":"Br J Haematol"},{"key":"256_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/asheducation-2011.1.215","volume":"2011","author":"F Cervantes","year":"2011","unstructured":"Cervantes F (2011) Management of essential thrombocythemia. Hematology Am Soc Hematol Educ Program 2011:215\u2013221. doi: 10.1182\/asheducation-2011.1.215","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"256_CR15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1442-200X.1994.tb03273.x","volume":"36","author":"N Cetingul","year":"1994","unstructured":"Cetingul N, Yener E, Oztop S, Nisli G, Soydan S (1994) Agnogenic myeloid metaplasia in childhood: a report of two cases and efficiency of intravenous high dose methylprednisolone treatment. Acta Paediatr Jpn 36:697\u2013700","journal-title":"Acta Paediatr Jpn"},{"key":"256_CR16","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/archinte.165.22.2651","volume":"165","author":"CS Chim","year":"2005","unstructured":"Chim CS, Kwong YL, Lie AK, Ma SK, Chan CC, Wong LG, Kho BC, Lee HK, Sim JP, Chan CH et al (2005) Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia. Arch Intern Med 165:2651\u20132658. doi: 10.1001\/archinte.165.22.2651","journal-title":"Arch Intern Med"},{"key":"256_CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ajh.23140","volume":"87","author":"MR DeLario","year":"2012","unstructured":"DeLario MR, Sheehan AM, Ataya R, Bertuch AA, Vega C 2nd, Webb CR, Lopez-Terrada D, Venkateswaran L (2012) Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis\u2013an entity different from adults. Am J Hematol 87:461\u2013464. doi: 10.1002\/ajh.23140","journal-title":"Am J Hematol"},{"key":"256_CR18","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A, Kosmider O, Le Couedic JP, Robert F, Alberdi A et al (2009) Mutation in TET2 in myeloid cancers. N Engl J Med 360:2289\u20132301. doi: 10.1056\/NEJMoa0810069","journal-title":"N Engl J Med"},{"key":"256_CR19","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1182\/blood-2003-10-3471","volume":"103","author":"J Ding","year":"2004","unstructured":"Ding J, Komatsu H, Wakita A, Kato-Uranishi M, Ito M, Satoh A, Tsuboi K, Nitta M, Miyazaki H, Iida S et al (2004) Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood 103:4198\u20134200. doi: 10.1182\/blood-2003-10-3471","journal-title":"Blood"},{"key":"256_CR20","first-page":"1207","volume":"89","author":"I Dobo","year":"2004","unstructured":"Dobo I, Boiret N, Lippert E, Girodon F, Mossuz P, Donnard M, Campos L, Pineau D, Bascans E, Praloran V et al (2004) A standardized endogenous megakaryocytic erythroid colony assay for the diagnosis of essential thrombocythemia. Haematologica 89:1207\u20131212","journal-title":"Haematologica"},{"key":"256_CR21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pbc.21910","volume":"52","author":"J Domm","year":"2009","unstructured":"Domm J, Calder C, Manes B, Crossno C, Correa H, Frangoul H (2009) Unrelated stem cell transplant for infantile idiopathic myelofibrosis. Pediatr Blood Cancer 52:893\u2013895. doi: 10.1002\/pbc.21910","journal-title":"Pediatr Blood Cancer"},{"key":"256_CR22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00043426-199909000-00005","volume":"21","author":"Y Dror","year":"1999","unstructured":"Dror Y, Zipursky A, Blanchette VS (1999) Essential thrombocythemia in children. J Pediatr Hematol Oncol 21:356\u2013363","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/bjh.12530","volume":"163","author":"R Fu","year":"2013","unstructured":"Fu R, Zhang L, Yang R (2013) Paediatric essential thrombocythaemia: clinical and molecular features, diagnosis and treatment. Br J Haematol 163:295\u2013302. doi: 10.1111\/bjh.12530","journal-title":"Br J Haematol"},{"key":"256_CR24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.leu.2404500","volume":"21","author":"N Gangat","year":"2007","unstructured":"Gangat N, Wolanskyj AP, McClure RF, Li CY, Schwager S, Wu W, Tefferi A (2007) Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients. Leukemia 21:270\u2013276. doi: 10.1038\/sj.leu.2404500","journal-title":"Leukemia"},{"key":"256_CR25","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood-2011-08-371328","volume":"119","author":"F Giona","year":"2012","unstructured":"Giona F, Teofili L, Moleti ML, Martini M, Palumbo G, Amendola A, Mazzucconi MG, Testi AM, Pignoloni P, Orlando SM et al (2012) Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome. Blood 119:2219\u20132227. doi: 10.1182\/blood-2011-08-371328","journal-title":"Blood"},{"key":"256_CR26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","volume":"353","author":"CN Harrison","year":"2005","unstructured":"Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, Wilkins BS, van der Walt JD, Reilly JT, Grigg AP et al (2005) Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 353:33\u201345. doi: 10.1056\/NEJMoa043800","journal-title":"N Engl J Med"},{"key":"256_CR27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1365-2141.2000.02239-7.x","volume":"110","author":"H Hasle","year":"2000","unstructured":"Hasle H (2000) Incidence of essential thrombocythaemia in children. Br J Haematol 110:751","journal-title":"Br J Haematol"},{"key":"256_CR28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPH.0b013e31828e548a","volume":"36","author":"M Henry","year":"2014","unstructured":"Henry M, Chitlur M, Rajpurkar M, Mastropietro CW, Poulik J, Ravindranath Y (2014) Myelofibrosis, hepatic extramedullary hematopoiesis and ascites associated with vitamin D deficiency in early infancy. J Pediatr Hematol Oncol 36:319\u2013321. doi: 10.1097\/MPH.0b013e31828e548a","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR29","first-page":"1125","volume-title":"Hematology: basic principles and practice","author":"R Hoffman","year":"2008","unstructured":"Hoffman R, Xu M, Finazzi G, Barbui T (2008) Primary myelofibrosis. In: Hoffman R, Benz EJ, Shattil SJ (eds) Hematology: basic principles and practice, 5th edn. Churchill Livingstone, Philadelphia, Pa, pp 1125\u20131148","edition":"5"},{"key":"256_CR30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/petr.12148","volume":"17","author":"AA Hussein","year":"2013","unstructured":"Hussein AA, Hamadah T, Domm J, Al-Zaben A, Frangoul H (2013) Allogeneic hematopoietic stem cell transplantation for infants with idiopathic myelofibrosis. Pediatr Transplant 17:815\u2013819. doi: 10.1111\/petr.12148","journal-title":"Pediatr Transplant"},{"key":"256_CR31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2009.01224.x","volume":"82","author":"K Hussein","year":"2009","unstructured":"Hussein K, Van Dyke DL, Tefferi A (2009) Conventional cytogenetics in myelofibrosis: literature review and discussion. Eur J Haematol 82:329\u2013338. doi: 10.1111\/j.1600-0609.2009.01224.x","journal-title":"Eur J Haematol"},{"key":"256_CR32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/pbc.23409","volume":"59","author":"O Ismael","year":"2012","unstructured":"Ismael O, Shimada A, Hama A, Sakaguchi H, Doisaki S, Muramatsu H, Yoshida N, Ito M, Takahashi Y, Akita N et al (2012) Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children. Pediatr Blood Cancer 59:530\u2013535. doi: 10.1002\/pbc.23409","journal-title":"Pediatr Blood Cancer"},{"key":"256_CR33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V51.2.189.189","volume":"51","author":"RJ Jacobson","year":"1978","unstructured":"Jacobson RJ, Salo A, Fialkow PJ (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 51:189\u2013194","journal-title":"Blood"},{"key":"256_CR34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1034\/j.1600-0609.2000.90236.x","volume":"65","author":"MK Jensen","year":"2000","unstructured":"Jensen MK, de Nully BP, Nielsen OJ, Hasselbalch HC (2000) Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area. Eur J Haematol 65:132\u2013139","journal-title":"Eur J Haematol"},{"key":"256_CR35","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1182\/blood-2008-08-175620","volume":"112","author":"K Kelly","year":"2008","unstructured":"Kelly K, McMahon C, Langabeer S, Eliwan H, O\u2019Marcaigh A, Smith OP (2008) Congenital JAK2V617F polycythemia vera: where does the genotype-phenotype diversity end? Blood 112:4356\u20134357. doi: 10.1182\/blood-2008-08-175620","journal-title":"Blood"},{"key":"256_CR36","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369:2379\u20132390. doi: 10.1056\/NEJMoa1311347","journal-title":"N Engl J Med"},{"key":"256_CR37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3324\/haematol.2013.092684","volume":"99","author":"N Kucine","year":"2014","unstructured":"Kucine N, Chastain KM, Mahler MB, Bussel JB (2014) Primary thrombocytosis in children. Haematologica 99:620\u2013628. doi: 10.3324\/haematol.2013.092684","journal-title":"Haematologica"},{"key":"256_CR38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0609.2006.00719.x","volume":"77","author":"H Lackner","year":"2006","unstructured":"Lackner H, Urban C, Benesch M, Moser A, Sovinz P, Schwinger W, Dornbusch HJ (2006) Long-term use of anagrelide in the treatment of children with essential thrombocythemia. Eur J Haematol 77:358\u2013359. doi: 10.1111\/j.1600-0609.2006.00719.x","journal-title":"Eur J Haematol"},{"key":"256_CR39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-3476(81)80769-X","volume":"98","author":"SO Lau","year":"1981","unstructured":"Lau SO, Ramsay NK, Smith CM 2nd, McKenna R, Kersey JH (1981) Spontaneous resolution of severe childhood myelofibrosis. J Pediatr 98:585\u2013588","journal-title":"J Pediatr"},{"key":"256_CR40","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","volume":"123","author":"P Lundberg","year":"2014","unstructured":"Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M et al (2014) Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 123:2220\u20132228. doi: 10.1182\/blood-2013-11-537167","journal-title":"Blood"},{"key":"256_CR41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2141.1987.tb06882.x","volume":"66","author":"LG Macdougall","year":"1987","unstructured":"Macdougall LG, Pettifor JM, Patel JM (1987) Bone growth and haemopoiesis: steroid reversible anaemia, myelofibrosis and increased bone formation in a child. Br J Haematol 66:5\u201310","journal-title":"Br J Haematol"},{"key":"256_CR42","first-page":"965","volume":"146","author":"AA Mallouh","year":"1992","unstructured":"Mallouh AA, Sa\u2019di AR (1992) Agnogenic myeloid metaplasia in children. Am J Dis Child 146:965\u2013967","journal-title":"Am J Dis Child"},{"key":"256_CR43","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","volume":"23","author":"R Marchioli","year":"2005","unstructured":"Marchioli R, Finazzi G, Landolfi R, Kutti J, Gisslinger H, Patrono C, Marilus R, Villegas A, Tognoni G, Barbui T (2005) Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol 23:2224\u20132232. doi: 10.1200\/JCO.2005.07.062","journal-title":"J Clin Oncol"},{"key":"256_CR44","first-page":"1306","volume":"89","author":"MG Mazzucconi","year":"2004","unstructured":"Mazzucconi MG, Redi R, Bernasconi S, Bizzoni L, Dragoni F, Latagliata R, Santoro C, Mandelli F (2004) A long-term study of young patients with essential thrombocythemia treated with anagrelide. Haematologica 89:1306\u20131313","journal-title":"Haematologica"},{"key":"256_CR45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1099-1069(199711)15:4<173::AID-HON610>3.0.CO;2-K","volume":"15","author":"RJ McNally","year":"1997","unstructured":"McNally RJ, Rowland D, Roman E, Cartwright RA (1997) Age and sex distributions of hematological malignancies in the U.K. Hematol Oncol 15:173\u2013189","journal-title":"Hematol Oncol"},{"key":"256_CR46","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMc1200349","volume":"366","author":"AJ Mead","year":"2012","unstructured":"Mead AJ, Rugless MJ, Jacobsen SE, Schuh A (2012) Germline JAK2 mutation in a family with hereditary thrombocytosis. N Engl J Med 366:967\u2013969. doi: 10.1056\/NEJMc1200349","journal-title":"N Engl J Med"},{"key":"256_CR47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I","volume":"61","author":"RA Mesa","year":"1999","unstructured":"Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A (1999) Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976\u20131995. Am J Hematol 61:10\u201315","journal-title":"Am J Hematol"},{"key":"256_CR48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.leukres.2006.12.002","volume":"31","author":"RA Mesa","year":"2007","unstructured":"Mesa RA, Verstovsek S, Cervantes F, Barosi G, Reilly JT, Dupriez B, Levine R, Le Bousse-Kerdiles MC, Wadleigh M, Campbell PJ et al (2007) Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leuk Res 31:737\u2013740. doi: 10.1016\/j.leukres.2006.12.002","journal-title":"Leuk Res"},{"key":"256_CR49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/152581601750289000","volume":"10","author":"JQ Mi","year":"2001","unstructured":"Mi JQ, Blanc-Jouvan F, Wang J, Sotto MF, Cousin F, Castinel A, Chauvet M, Sotto JJ, Polack B, Mossuz P (2001) Endogenous megakaryocytic colony formation and thrombopoietin sensitivity of megakaryocytic progenitor cells are useful to distinguish between essential thrombocythemia and reactive thrombocytosis. J Hematother Stem Cell Res 10:405\u2013409. doi: 10.1089\/152581601750289000","journal-title":"J Hematother Stem Cell Res"},{"key":"256_CR50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-996107","volume":"23","author":"JJ Michiels","year":"1997","unstructured":"Michiels JJ, Juvonen E (1997) Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Semin Thromb Hemost 23:339\u2013347. doi: 10.1055\/s-2007-996107","journal-title":"Semin Thromb Hemost"},{"key":"256_CR51","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/MPH.0b013e31828800cc","volume":"35","author":"B Mitton","year":"2013","unstructured":"Mitton B, de Oliveira S, Pullarkat ST, Moore TB (2013) Stem cell transplantation in primary myelofibrosis of childhood. J Pediatr Hematol Oncol 35:e120\u2013e122. doi: 10.1097\/MPH.0b013e31828800cc","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ejh.12256","volume":"92","author":"O Moulard","year":"2014","unstructured":"Moulard O, Mehta J, Fryzek J, Olivares R, Iqbal U, Mesa RA (2014) Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Eur J Haematol 92:289\u2013297. doi: 10.1111\/ejh.12256","journal-title":"Eur J Haematol"},{"key":"256_CR53","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","volume":"369","author":"J Nangalia","year":"2013","unstructured":"Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC, Avezov E, Li J, Kollmann K, Kent DG et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369:2391\u20132405. doi: 10.1056\/NEJMoa1312542","journal-title":"N Engl J Med"},{"key":"256_CR54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000204514","volume":"89","author":"S Ozsoylu","year":"1993","unstructured":"Ozsoylu S (1993) Megadose methylprednisolone for myelofibrosis. Acta Haematol 89:167","journal-title":"Acta Haematol"},{"key":"256_CR55","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3324\/haematol.13346","volume":"93","author":"F Passamonti","year":"2008","unstructured":"Passamonti F, Rumi E, Arcaini L, Boveri E, Elena C, Pietra D, Boggi S, Astori C, Bernasconi P, Varettoni M et al (2008) Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients. Haematologica 93:1645\u20131651. doi: 10.3324\/haematol.13346","journal-title":"Haematologica"},{"key":"256_CR56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","volume":"117","author":"F Passamonti","year":"2004","unstructured":"Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M, Orlandi E, Arcaini L, Brusamolino E, Pascutto C et al (2004) Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med 117:755\u2013761. doi: 10.1016\/j.amjmed.2004.06.032","journal-title":"Am J Med"},{"key":"256_CR57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0369-8114(00)00025-0","volume":"49","author":"TC Pearson","year":"2001","unstructured":"Pearson TC, Messinezy M (2001) Idiopathic erythrocytosis, diagnosis and clinical management. Pathol Biol 49:170\u2013177","journal-title":"Pathol Biol"},{"key":"256_CR58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0929-693X(96)80007-8","volume":"3","author":"H Pilorget","year":"1996","unstructured":"Pilorget H, Bangui A, Adam M, Leverger G (1996) Myelofibrosis regressing under corticotherapy and intravenous immunoglobulins in an infant. Arch Pediatr 3:40\u201343","journal-title":"Arch Pediatr"},{"key":"256_CR59","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood-2006-04-014746","volume":"108","author":"ML Randi","year":"2006","unstructured":"Randi ML, Putti MC, Scapin M, Pacquola E, Tucci F, Micalizzi C, Zanesco L, Fabris F (2006) Pediatric patients with essential thrombocythemia are mostly polyclonal and V617FJAK2 negative. Blood 108:3600\u20133602. doi: 10.1182\/blood-2006-04-014746","journal-title":"Blood"},{"key":"256_CR60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.20906","volume":"50","author":"H Reinhard","year":"2008","unstructured":"Reinhard H, Klingebiel T, Lang P, Bader P, Niethammer D, Graf N (2008) Stem cell transplantation for polycythemia vera. Pediatr Blood Cancer 50:124\u2013126. doi: 10.1002\/pbc.20906","journal-title":"Pediatr Blood Cancer"},{"key":"256_CR61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2008-01-134858","volume":"112","author":"DE Rollison","year":"2008","unstructured":"Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA, Edwards BK, List AF (2008) Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 112:45\u201352. doi: 10.1182\/blood-2008-01-134858","journal-title":"Blood"},{"key":"256_CR62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043426-199605000-00025","volume":"18","author":"HC Rossbach","year":"1996","unstructured":"Rossbach HC, Grana NH, Chamizo W, Barrios NJ, Barbosa JL (1996) Successful allogeneic bone marrow transplantation for agnogenic myeloid metaplasia in a 3-year-old boy. J Pediatr Hematol Oncol 18:213\u2013215","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR63","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1046\/j.1365-2141.2001.02622.x","volume":"112","author":"A Sah","year":"2001","unstructured":"Sah A, Minford A, Parapia LA (2001) Spontaneous remission of juvenile idiopathic myelofibrosis. Br J Haematol 112:1083","journal-title":"Br J Haematol"},{"key":"256_CR64","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1365-2141.1996.5051046.x","volume":"93","author":"M Sekhar","year":"1996","unstructured":"Sekhar M, Prentice HG, Popat U, Anderson D, Janmohammed R, Roberts I, Britt RP (1996) Idiopathic myelofibrosis in children. Br J Haematol 93:394\u2013397","journal-title":"Br J Haematol"},{"key":"256_CR65","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1097\/MPH.0b013e3182346cc5","volume":"34","author":"F Shaikh","year":"2012","unstructured":"Shaikh F, Naithani R, Kirby-Allen M, Doyle J (2012) Allogeneic cord hematopoietic stem cell transplantation in an infant with primary myelofibrosis. J Pediatr Hematol Oncol 34:e199\u2013e201. doi: 10.1097\/MPH.0b013e3182346cc5","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR66","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00043426-200406000-00013","volume":"26","author":"S Shankar","year":"2004","unstructured":"Shankar S, Choi JK, Dermody TS, Head DR, Bunin N, Iannone R (2004) Pulmonary hypertension complicating bone marrow transplantation for idiopathic myelofibrosis. J Pediatr Hematol Oncol 26:393\u2013397","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR67","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00043426-200403000-00005","volume":"26","author":"A Sheikha","year":"2004","unstructured":"Sheikha A (2004) Fatal familial infantile myelofibrosis. J Pediatr Hematol Oncol 26:164\u2013168","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR68","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/adc.55.11.888","volume":"55","author":"CA Sieff","year":"1980","unstructured":"Sieff CA, Malleson P (1980) Familial myelofibrosis. Arch Dis Child 55:888\u2013893","journal-title":"Arch Dis Child"},{"key":"256_CR69","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MPH.0b013e31829cdea0","volume":"35","author":"JS Slone","year":"2013","unstructured":"Slone JS, Smith MC, Seegmiller AC, Sidonio RF, Yang E (2013) Idiopathic myelofibrosis in children: primary myelofibrosis, essential thrombocythemia, or transient process? J Pediatr Hematol Oncol 35:559\u2013565. doi: 10.1097\/MPH.0b013e31829cdea0","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR70","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1182\/blood-2012-12-475566","volume":"121","author":"P Stepensky","year":"2013","unstructured":"Stepensky P, Saada A, Cowan M, Tabib A, Fischer U, Berkun Y, Saleh H, Simanovsky N, Kogot-Levin A, Weintraub M et al (2013) The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy. Blood 121:5078\u20135087. doi: 10.1182\/blood-2012-12-475566","journal-title":"Blood"},{"key":"256_CR71","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/petr.12169","volume":"17","author":"P Stepensky","year":"2013","unstructured":"Stepensky P, Simanovsky N, Averbuch D, Gross M, Yanir A, Mevorach D, Elpeleg O, Weintraub M (2013) VPS 45-associated primary infantile myelofibrosis\u2013successful treatment with hematopoietic stem cell transplantation. Pediatr Transplant 17:820\u2013825. doi: 10.1111\/petr.12169","journal-title":"Pediatr Transplant"},{"key":"256_CR72","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, International Agency for Research on Cancer, World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, IARC, Lyon"},{"key":"256_CR73","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","volume":"342","author":"A Tefferi","year":"2000","unstructured":"Tefferi A (2000) Myelofibrosis with myeloid metaplasia. N Engl J Med 342:1255\u20131265. doi: 10.1056\/NEJM200004273421706","journal-title":"N Engl J Med"},{"key":"256_CR74","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1200\/JCO.2004.00.9316","volume":"23","author":"A Tefferi","year":"2005","unstructured":"Tefferi A (2005) Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol 23:8520\u20138530. doi: 10.1200\/JCO.2004.00.9316","journal-title":"J Clin Oncol"},{"key":"256_CR75","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/leu.2014.57","volume":"28","author":"A Tefferi","year":"2014","unstructured":"Tefferi A, Guglielmelli P, Lasho TL, Rotunno G, Finke C, Mannarelli C, Belachew AA, Pancrazzi A, Wassie EA, Ketterling RP et al (2014) CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients. Leukemia 28:1494\u20131500. doi: 10.1038\/leu.2014.57","journal-title":"Leukemia"},{"key":"256_CR76","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","volume":"110","author":"A Tefferi","year":"2007","unstructured":"Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, Barosi G, Verstovsek S, Birgegard G, Mesa R et al (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 110:1092\u20131097. doi: 10.1182\/blood-2007-04-083501","journal-title":"Blood"},{"key":"256_CR77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","volume":"22","author":"A Tefferi","year":"2008","unstructured":"Tefferi A, Vardiman JW (2008) Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 22:14\u201322. doi: 10.1038\/sj.leu.2404955","journal-title":"Leukemia"},{"key":"256_CR78","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/leu.2013.302","volume":"28","author":"E Tenedini","year":"2014","unstructured":"Tenedini E, Bernardis I, Artusi V, Artuso L, Roncaglia E, Guglielmelli P, Pieri L, Bogani C, Biamonte F, Rotunno G et al (2014) Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. Leukemia 28:1052\u20131059. doi: 10.1038\/leu.2013.302","journal-title":"Leukemia"},{"key":"256_CR79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3324\/haematol.12002","volume":"93","author":"L Teofili","year":"2008","unstructured":"Teofili L, Foa R, Giona F, Larocca LM (2008) Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients? Haematologica 93:169\u2013172. doi: 10.3324\/haematol.12002","journal-title":"Haematologica"},{"key":"256_CR80","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1200\/JCO.2006.08.6884","volume":"25","author":"L Teofili","year":"2007","unstructured":"Teofili L, Giona F, Martini M, Cenci T, Guidi F, Torti L, Palumbo G, Amendola A, Foa R, Larocca LM (2007) Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. J Clin Oncol 25:1048\u20131053. doi: 10.1200\/JCO.2006.08.6884","journal-title":"J Clin Oncol"},{"key":"256_CR81","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1182\/blood-2007-06-094276","volume":"110","author":"L Teofili","year":"2007","unstructured":"Teofili L, Giona F, Martini M, Cenci T, Guidi F, Torti L, Palumbo G, Amendola A, Leone G, Foa R et al (2007) The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia. Blood 110:3384\u20133386. doi: 10.1182\/blood-2007-06-094276","journal-title":"Blood"},{"key":"256_CR82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3324\/haematol.2009.007542","volume":"95","author":"L Teofili","year":"2010","unstructured":"Teofili L, Giona F, Torti L, Cenci T, Ricerca BM, Rumi C, Nunes V, Foa R, Leone G, Martini M et al (2010) Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis. Haematologica 95:65\u201370. doi: 10.3324\/haematol.2009.007542","journal-title":"Haematologica"},{"key":"256_CR83","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90:1128\u20131132","journal-title":"Haematologica"},{"key":"256_CR84","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1182\/blood-2010-07-293761","volume":"117","author":"J Thiele","year":"2011","unstructured":"Thiele J, Kvasnicka HM, Mullauer L, Buxhofer-Ausch V, Gisslinger B, Gisslinger H (2011) Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. Blood 117:5710\u20135718. doi: 10.1182\/blood-2010-07-293761","journal-title":"Blood"},{"key":"256_CR85","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/leu.2013.119","volume":"27","author":"AM Vannucchi","year":"2013","unstructured":"Vannucchi AM, Lasho TL, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C et al (2013) Mutations and prognosis in primary myelofibrosis. Leukemia 27:1861\u20131869. doi: 10.1038\/leu.2013.119","journal-title":"Leukemia"},{"key":"256_CR86","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100:2292\u20132302. doi: 10.1182\/blood-2002-04-1199","journal-title":"Blood"},{"key":"256_CR87","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.humpath.2014.07.017","volume":"45","author":"ME Vergara-Lluri","year":"2014","unstructured":"Vergara-Lluri ME, Piatek CI, Pullarkat V, Siddiqi IN, O\u2019Connell C, Feinstein DI, Brynes RK (2014) Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature. Hum Pathol 45:2183\u20132191. doi: 10.1016\/j.humpath.2014.07.017","journal-title":"Hum Pathol"},{"key":"256_CR88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1301296","volume":"369","author":"T Vilboux","year":"2013","unstructured":"Vilboux T, Lev A, Malicdan MC, Simon AJ, Jarvinen P, Racek T, Puchalka J, Sood R, Carrington B, Bishop K et al (2013) A congenital neutrophil defect syndrome associated with mutations in VPS45. N Engl J Med 369:54\u201365. doi: 10.1056\/NEJMoa1301296","journal-title":"N Engl J Med"},{"key":"256_CR89","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2007-05-091850","volume":"111","author":"BS Wilkins","year":"2008","unstructured":"Wilkins BS, Erber WN, Bareford D, Buck G, Wheatley K, East CL, Paul B, Harrison CN, Green AR, Campbell PJ (2008) Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. Blood 111:60\u201370. doi: 10.1182\/blood-2007-05-091850","journal-title":"Blood"},{"key":"256_CR90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4065\/81.2.159","volume":"81","author":"AP Wolanskyj","year":"2006","unstructured":"Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A (2006) Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 81:159\u2013166. doi: 10.4065\/81.2.159","journal-title":"Mayo Clin Proc"},{"key":"256_CR91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0022-3476(89)80785-1","volume":"114","author":"S Yetgin","year":"1989","unstructured":"Yetgin S, Ozsoylu S, Ruacan S, Tekinalp G, Sarialioglu F (1989) Vitamin D-deficiency rickets and myelofibrosis. J Pediatr 114:213\u2013217","journal-title":"J Pediatr"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-015-0256-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12308-015-0256-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-015-0256-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T20:39:19Z","timestamp":1652992759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12308-015-0256-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,2]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1007\/s12308-015-0256-1","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,2]]}}}